ArticleFrontiers in pharmacology2025

Chinese population may require further venetoclax dose reduction beyond guidelines when combined with voriconazole: real-world evidence from China.

Rongrong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.